247 related articles for article (PubMed ID: 29237267)
1. Unsaturated Squalene Content in Emulsion Vaccine Adjuvants Plays a Crucial Role in ROS-Mediated Antigen Uptake and Cellular Immunity.
Huang CH; Huang CY; Huang MH
Mol Pharm; 2018 Feb; 15(2):420-429. PubMed ID: 29237267
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Freeze-Drying Oil-in-Water Emulsion Adjuvants and Subunit Proteins to Enable Single-Vial Vaccine Drug Products.
Iyer V; Cayatte C; Marshall JD; Sun J; Schneider-Ohrum K; Maynard SK; Rajani GM; Bennett AS; Remmele RL; Bishop SM; McCarthy MP; Muralidhara BK
J Pharm Sci; 2017 Jun; 106(6):1490-1498. PubMed ID: 28259764
[TBL] [Abstract][Full Text] [Related]
3. Squalane-based emulsion vaccine delivery system: composition with murabutide activate Th1 response.
Kantipakala R; Bonam SR; Vemireddy S; Miryala S; Halmuthur M SK
Pharm Dev Technol; 2019 Mar; 24(3):269-275. PubMed ID: 29688119
[TBL] [Abstract][Full Text] [Related]
4. Squalene and squalane emulsions as adjuvants.
Allison AC
Methods; 1999 Sep; 19(1):87-93. PubMed ID: 10525443
[TBL] [Abstract][Full Text] [Related]
5. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(γ-glutamic acid) nanoparticles.
Shima F; Akagi T; Uto T; Akashi M
Biomaterials; 2013 Dec; 34(37):9709-16. PubMed ID: 24016848
[TBL] [Abstract][Full Text] [Related]
6. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.
Calabro S; Tritto E; Pezzotti A; Taccone M; Muzzi A; Bertholet S; De Gregorio E; O'Hagan DT; Baudner B; Seubert A
Vaccine; 2013 Jul; 31(33):3363-9. PubMed ID: 23684834
[TBL] [Abstract][Full Text] [Related]
7. Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion.
Haensler J; Probeck P; Su J; Piras F; Dalençon F; Cotte JF; Chambon V; Iqbal SM; Hawkins L; Burdin N
Int J Pharm; 2015; 486(1-2):99-111. PubMed ID: 25794609
[TBL] [Abstract][Full Text] [Related]
8. Antigen delivery for cross priming via the emulsion vaccine adjuvants.
Shen SS; Yang YW
Vaccine; 2012 Feb; 30(9):1560-71. PubMed ID: 22230588
[TBL] [Abstract][Full Text] [Related]
9. Development of Squalene-Based Oil-in-Water Emulsion Adjuvants Using a Self-Emulsifying Drug Delivery System for Enhanced Antigen-Specific Antibody Titers.
Chae GE; Kim DW; Jin HE
Int J Nanomedicine; 2022; 17():6221-6231. PubMed ID: 36531114
[TBL] [Abstract][Full Text] [Related]
10. Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy.
Huang CH; Huang CY; Cheng CP; Dai SH; Chen HW; Leng CH; Chong P; Liu SJ; Huang MH
Sci Rep; 2016 Nov; 6():36732. PubMed ID: 27827451
[TBL] [Abstract][Full Text] [Related]
11. A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation.
Deng J; Cai W; Jin F
Int J Pharm; 2014 Jul; 468(1-2):187-95. PubMed ID: 24704309
[TBL] [Abstract][Full Text] [Related]
12. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake.
Liang F; Lindgren G; Sandgren KJ; Thompson EA; Francica JR; Seubert A; De Gregorio E; Barnett S; O'Hagan DT; Sullivan NJ; Koup RA; Seder RA; Loré K
Sci Transl Med; 2017 Jun; 9(393):. PubMed ID: 28592561
[TBL] [Abstract][Full Text] [Related]
13. Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family.
Fox CB; Van Hoeven N; Granger B; Lin S; Guderian JA; Hartwig A; Marlenee N; Bowen RA; Soultanov V; Carter D
Phytomedicine; 2019 Nov; 64():152927. PubMed ID: 31465981
[TBL] [Abstract][Full Text] [Related]
14. Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants.
Iyer V; Cayatte C; Guzman B; Schneider-Ohrum K; Matuszak R; Snell A; Rajani GM; McCarthy MP; Muralidhara B
Hum Vaccin Immunother; 2015; 11(7):1853-64. PubMed ID: 26090563
[TBL] [Abstract][Full Text] [Related]
15. Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells.
Cioncada R; Maddaluno M; Vo HTM; Woodruff M; Tavarini S; Sammicheli C; Tortoli M; Pezzicoli A; De Gregorio E; Carroll MC; D'Oro U; Piccioli D
PLoS One; 2017; 12(10):e0185843. PubMed ID: 29088224
[TBL] [Abstract][Full Text] [Related]
16. An alternative renewable source of squalene for use in emulsion adjuvants.
Brito LA; Chan M; Baudner B; Gallorini S; Santos G; O'Hagan DT; Singh M
Vaccine; 2011 Aug; 29(37):6262-8. PubMed ID: 21723355
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice.
Zhang J; Miao J; Han X; Lu Y; Deng B; Lv F; Zhao Y; Ding C; Hou J
BMC Vet Res; 2018 Dec; 14(1):415. PubMed ID: 30577861
[TBL] [Abstract][Full Text] [Related]
18. Impact of antigen-adjuvant associations on antigen uptake and antigen-specific humoral immunity in mice following intramuscular injection.
Huang CH; Huang CY; Huang MH
Biomed Pharmacother; 2019 Oct; 118():109373. PubMed ID: 31545268
[TBL] [Abstract][Full Text] [Related]
19. An immunopotentiator, ophiopogonin D, encapsulated in a nanoemulsion as a robust adjuvant to improve vaccine efficacy.
Tong YN; Yang LY; Yang Y; Song Z; Peng LS; Gao JN; Zeng H; Zou QM; Sun HW; Mao XH
Acta Biomater; 2018 Sep; 77():255-267. PubMed ID: 30031164
[TBL] [Abstract][Full Text] [Related]
20. Squalene-based oil-in-water emulsion adjuvants perturb metabolism of neutral lipids and enhance lipid droplet formation.
Kalvodova L
Biochem Biophys Res Commun; 2010 Mar; 393(3):350-5. PubMed ID: 20018176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
